Browse the evidence

Exercise-induced myokines (exerkines) such as SDF1, irisin, and SPARC counteract muscle wasting in diseases like cancer cachexia, COPD, and aging by modulating protein synthesis and degradation pathways.

If you are dealing with muscle loss due to illness or age, regular physical activity is a key treatment. It triggers your muscles to release protective proteins (myokines) that help stop muscle breakdown. You do not need to be an athlete; even moderate aerobic or resistance exercise can help restore these protective factors.

Continuous Positive Airway Pressure (CPAP) treatment for Obstructive Sleep Apnea (OSA) improves insulin resistance in patients without diabetes.

If you have Obstructive Sleep Apnea, using CPAP therapy as prescribed can improve your insulin resistance and metabolic health. Consistent use is key to realizing these benefits.

Time-Restricted Feeding (TRF) aligned with the active period improves metabolic health markers (body weight, cholesterol, insulin levels) in mice without reducing overall food intake.

Consider Time-Restricted Feeding (TRF) by limiting your eating window to 8 hours per day, ideally aligned with your active period. This approach can improve metabolic health markers like body weight and cholesterol without requiring caloric restriction, by aligning food intake with your body's circadian rhythms.

Continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea syndrome (OSAS) significantly reduces in vitro platelet aggregability induced by epinephrine, restoring physiological diurnal patterns.

If you have obstructive sleep apnea, using your CPAP machine consistently every night for at least six months can significantly improve your blood's tendency to clot (platelet aggregability). This is a key mechanism for reducing your risk of heart attacks and strokes associated with sleep apnea. Ensure your device is delivering the prescribed pressure and that you are using it nightly to achieve these cardiovascular benefits.

Dietary polyphenols, specifically (-)-epicatechin and olive-derived polyphenols, extend healthspan and lifespan in animal models by enhancing mitochondrial function, reducing oxidative stress, and modulating inflammatory pathways.

Focus on consuming polyphenol-rich whole foods like cocoa, olive oil, berries, and tea as part of a balanced diet. While supplements exist, the evidence for extending human lifespan is strongest when derived from food sources, particularly in older adults or those with metabolic issues. Do not expect immediate results; these are long-term preventive strategies.

The PPARδ agonist GW501516 increases glucose uptake in human skeletal muscle cells via an AMPK-dependent mechanism that is independent of PPARδ expression.

This research identifies a specific mechanism by which PPARδ activation improves glucose handling in muscle cells: it bypasses the PPARδ receptor itself to activate AMPK, a key energy sensor. While GW501516 is a research chemical and not a consumer supplement, this finding suggests that strategies which activate AMPK (such as exercise or specific metabolic stressors) may mimic this glucose-uptake benefit independently of PPARδ expression levels.

The PPARδ agonist GW501516 increases fatty acid oxidation in human skeletal muscle through a mechanism that requires both PPARδ expression and functional AMPK.

This study shows that maximizing fat oxidation in muscle cells requires both PPARδ and AMPK to be active. While GW501516 is not a consumer product, this suggests that natural methods activating both pathways (like high-intensity exercise which activates AMPK and can upregulate PPARδ over time) are synergistic for lipid metabolism.

Metformin administration is associated with a reduced incidence of multiple age-related diseases and all-cause mortality in both diabetic and non-diabetic populations.

If you are taking metformin for diabetes, you may already be benefiting from reduced risks of age-related conditions. For non-diabetics considering metformin for longevity, the evidence is promising but not yet definitive (TAME trial pending). Discuss with your doctor, especially regarding kidney function and potential side effects like GI distress, which can often be managed with dosing strategies.

Metformin treatment improves outcomes in osteoarthritis (OA) by reducing inflammation, protecting articular cartilage via the AMPK pathway, and reducing body weight.

For those with osteoarthritis, especially if overweight, metformin (if prescribed for diabetes) may offer additional joint protection and pain relief. This is likely due to its anti-inflammatory properties and weight loss effects. Consult your doctor about whether existing metformin therapy is contributing to joint health.

Metformin use is associated with a reduced risk of various cancers, including breast, colorectal, and pancreatic cancer, though effects on pancreatic cancer prognosis are mixed.

If you have diabetes and take metformin, you may have a lower risk of developing certain cancers like breast and colorectal cancer. However, it is not a cancer treatment itself. Do not stop taking metformin to 'prevent' cancer without consulting your doctor, as the benefits for diabetes management are primary.

In obese adolescents, elevated levels of Faecalibacterium prausnitzii and Actinomyces are associated with increased energy recovery from unabsorbed carbohydrates, contributing to obesity phenotypes.

For obese adolescents, gut bacteria play a specific role in extracting energy from food. High levels of Faecalibacterium prausnitzii may mean your body is extracting more calories from carbohydrates than expected. This suggests that dietary strategies focusing on carbohydrate quality and quantity might need to be tailored specifically for adolescents, distinct from adult approaches.

Obese adolescents exhibit distinct metabolic pathway enrichment in their gut microbiota, specifically involving primary bile acid biosynthesis and carbohydrate metabolism (fructose, mannose, galactose), compared to normal weight adolescents.

The gut bacteria of obese adolescents are metabolically active in ways that may promote weight gain, specifically by breaking down sugars and producing primary bile acids. This suggests that dietary interventions for adolescents should consider not just total calories, but the specific types of carbohydrates and fats that feed these bacterial pathways.

Fragmentation of the rest-activity rhythm (intradaily variability) is significantly associated with age-related cognitive decline in elderly individuals, independent of age, gender, and cardiovascular risk factors.

For older adults, maintaining a stable daily routine is as important for brain health as sleep duration. Fragmented activity (frequent transitions between rest and activity throughout the day) is linked to poorer cognitive performance. Establishing a consistent, strong circadian rhythm—regular sleep times, regular meal times, and regular daytime activity—may help mitigate age-related cognitive decline, particularly in mental speed and executive function.

Chronic cold exposure induces white-to-brown adipocyte transdifferentiation, increasing energy expenditure and protecting against obesity and type 2 diabetes.

Exposure to cold temperatures can trigger your body to convert energy-storing white fat into energy-burning brown-like fat (beige fat). This process increases your metabolic rate and helps protect against obesity and type 2 diabetes. While you don't need to freeze yourself, understanding this mechanism highlights the importance of factors like exercise (which releases irisin) and potentially cold exposure in managing metabolic health. Future treatments may target these pathways pharmacologically.

A 45-year decline in household management energy expenditure (HMEE) in women, driven by automation and increased workforce participation, has contributed to the rise in obesity by creating a chronic positive energy balance that is not fully offset by increases in leisure-time physical activity.

Recognize that modern conveniences (dishwashers, microwaves, pre-packaged foods) and increased workforce participation have significantly reduced your daily energy expenditure, even if you don't feel 'active.' To maintain weight, you cannot rely on housework alone; you must intentionally incorporate physical activity into your routine, as leisure-time exercise has not historically compensated for these losses.

A single bout of heavy resistance exercise transiently elevates mRNA levels of myogenic regulatory factors (myogenin, MyoD, MRF4) in human skeletal muscle, suggesting their involvement in regulating hypertrophy and fiber-type transitions.

Performing heavy resistance training triggers immediate genetic signals in your muscles that help build size and change fiber types. You do not need to optimize anything other than performing the exercise with sufficient intensity (heavy loads) to trigger this response. The body's molecular machinery handles the rest during recovery.

A single bout of heavy resistance exercise decreases the mRNA content of the IGF-IEa isoform during the initial recovery phase (1-6 hours), while the MGF (IGF-IEc) isoform remains unaffected.

After heavy lifting, your body temporarily reduces the production of one specific type of IGF-I (IGF-IEa) in the first few hours, while maintaining the muscle-specific version (MGF). This is a normal part of the body's regulatory process and does not mean your muscle-building potential is compromised. Focus on consistent training rather than worrying about immediate molecular fluctuations.

Treatment with omega-3 polyunsaturated fatty acids (specifically EPA and DHA) suppresses macrophage inflammation by activating the AMPK/SIRT1 pathway, which deacetylates the NF-kB subunit p65 and inhibits its signaling.

This research explains the biological mechanism behind why omega-3s (EPA/DHA) are considered anti-inflammatory: they activate cellular energy sensors (AMPK/SIRT1) that turn off inflammatory signals (NF-kB). While this is a cellular study, it supports the general recommendation of omega-3s for managing inflammation, particularly in the context of metabolic health.

Higher circulating levels of phospholipid metabolites, specifically choline, glycerophosphoethanolamine, and glycerophosphorylcholine (GPC), are associated with an insulin-sensitive phenotype in obese individuals, distinguishing them from obese insulin-resistant individuals.

This research suggests that for obese individuals, metabolic health (specifically insulin sensitivity) can be distinguished by blood levels of choline and related phospholipids. Higher levels of these metabolites are linked to a protective, insulin-sensitive state. This implies that metabolic health is not uniform across all obese individuals and may be assessed through specific biomarkers rather than weight alone.

Increased levels of specific fatty acid metabolites (3-hydroxylaurate, 3-hydroxyoctanoate, 3-hydroxydecanoate, 3-hydroxymyristate) and decreased levels of 1,5-anhydroglucitol (1,5-AG) and dimethylarginine (ADMA+SDMA) are associated with disease progression from insulin resistance to Type 2 Diabetes.

For individuals with obesity and insulin resistance, monitoring specific fatty acid metabolites and 1,5-AG levels may provide early warning signs of progression to Type 2 Diabetes. Decreasing 1,5-AG and increasing certain hydroxy-fatty acids are associated with this progression, suggesting these could be valuable markers for early intervention.

Marine algae-derived compounds (fucoxanthin, alginates, fucoidans, phlorotannins) act as anti-obesity agents through mechanisms including pancreatic lipase inhibition, suppression of adipocyte differentiation, and enhancement of energy expenditure.

Marine algae extracts like fucoxanthin and alginates show promise for weight management by blocking fat absorption and increasing energy burn in lab studies. However, current human evidence is limited to short-term effects on satiety or specific supplements. Do not expect these to replace diet and exercise, and be aware that they are not yet approved as standalone obesity drugs due to a lack of long-term human data.

High protein-to-carbohydrate (P:C) ratios shorten lifespan in insects, potentially via TOR pathway activation, while low P:C ratios extend lifespan via AMPK activation, unless obesity ensues.

In insects, high protein shortens life via TOR, and low protein extends life via AMPK, but too little protein causes obesity. For humans, this implies a 'Goldilocks' zone for protein: too high may accelerate aging, too low may cause obesity, and the optimal balance is likely species-specific.

Specific bioactive compounds in the Mediterranean Diet, particularly oleuropein and hydroxytyrosol from extra virgin olive oil, exert anti-inflammatory and epigenetic effects that may prevent neurodegenerative diseases and colorectal cancer.

Ensure your extra virgin olive oil is high quality and unrefined to preserve phenolic compounds like oleuropein. These compounds are linked to anti-inflammatory and potential neuroprotective benefits, though human dosing for specific disease prevention is not yet fully established.

Marked subclinical hypothyroidism (TSH > 10 mIU/L) is significantly associated with increased odds of prevalent metabolic syndrome, but this association may be confounded by thyroid hormone replacement therapy use.

For older adults with significantly elevated TSH (>10 mIU/L), there is a higher risk of metabolic syndrome, particularly high triglycerides and low HDL. However, this risk is heavily influenced by whether the patient is taking thyroid medication. If you are not on medication, your risk profile is less clear. Regular monitoring of lipid levels is recommended for this group.